Our analysis reveals a notable specificity in our population compared to the data documented in the literature, especially in patients with PV, where 42% of these patients did not present the JAK2 V617F variant or other pathogenic genetic alterations along the coding region of JAK2, as established by WHO diagnostic criteria3. Here, JAK2 is linked to acquired polycythemia vera.